Pirenzepine Dihydrochloride is a selective M1 muscarinic receptor antagonist within the antispasmodic class of pharmaceutical agents. Clinically, it is used to manage peptic ulcer disease by inhibiting… Read more
Pirenzepine Dihydrochloride is a selective M1 muscarinic receptor antagonist within the antispasmodic class of pharmaceutical agents. Clinically, it is used to manage peptic ulcer disease by inhibiting gastric acid secretion and alleviating smooth muscle spasms associated with gastrointestinal conditions. This category provides access to high-quality materials essential for rigorous pharmaceutical analysis, including Pirenzepine Dihydrochloride reference standards used for method development and quality control. Researchers can utilize the listed pharmacopeial and non-pharmacopeial impurities for precise impurity profiling and stability testing to ensure regulatory compliance. Additionally, stable isotope-labelled compounds are available to serve as reliable internal standards, facilitating accurate quantification in complex matrices during chromatographic analysis. These analytical tools are vital for ensuring the efficacy, safety, and consistency of the parent drug throughout its lifecycle.